Abstract:BACKGROUND: Galangin (GLN), a pure natural flavonoid compound found in plants, has been shown to exert anti-cancer effects against multiple cancer types, including glioma. However, its underlying molecular mechanism remains unclear. Epithelial-to-mesenchymal transition (EMT) performs an important function in the genesis and development of cancer. Skp2, a pivotal component of SCF<sup>Skp2</sup> E3 ubiquitin ligase, has been shown to function as an oncogene in GBM invasion that contributes to the EMT process. Thus, we explored whether GLN inhibited Skp2-mediated EMT and the mechanism underlying the Skp2 degradation pathway.METHODS: CCK-8 assay, wound healing assay and transwell assay were used to examine cell proliferation, migration, and invasion after treatment with or without GLN. RT-PCR and Western blotting analysis were performed to evaluate mRNA and protein expression, respectively. Co-immunoprecipitation was conducted to detect ubiquitinated Skp2 levels in vitro and in vivo after GLN treatment. Bioluminescence imaging was performed to examine the intracranial tumor size of U87 xenograft mice. Microscale thermophoresis (MST) experiment was used to detect interactions between Skp2 and GLN.RESULTS: GLN suppressed GBM cell growth, migration, and invasion, and also downregulated the expression of Skp2 and mesenchymal markers (Zeb1, N-cadherin, snail, vimentin) in vitro. Moreover, the overexpression of Skp2 in GBM cells decreased the effect of GLN on EMT. Furthermore, we demonstrated that GLN degraded skp2 protein through the ubiquitination proteasome pathway and directly interacted with skp2 protein, as shown through the MST assay.CONCLUSION: This study is the first to identify Skp2 as a novel target of GLN for the treatment of GBM and report of Skp2 protein degradation in a ubiquitination proteasome pathway. Results from our study indicated the potential of GLN for the treatment of GBM through ubiquitin-mediated degradation of Skp2.

Silibinin suppresses glioblastoma cell growth, invasion, stemness, and glutamine metabolism by YY1/SLC1A5 pathway

S100B Suppression Alters Polarization of Infiltrating Myeloid-Derived Cells in Gliomas and Inhibits Tumor Growth.

Silibinin Induced Human Glioblastoma Cell Apoptosis Concomitant with Autophagy Through Simultaneous Inhibition of Mtor and YAP

Functional analysis of the short splicing variant encoded by CHI3L1/YKL-40 in glioblastoma

Silibinin-induced glioma cell apoptosis by PI3K-mediated but Akt-independent downregulation of FoxM1 expression.

Autophagy Activated by Silibinin Contributes to Glioma Cell Death Via Induction of Oxidative Stress-Mediated BNIP3-dependent Nuclear Translocation of AIF.

Silibinin Induces Apoptosis Through Inhibition of the Mtor-Gli1-bcl2 Pathway in Renal Cell Carcinoma.

Transcription factor YY1-activated GNG5 facilitates glioblastoma cell growth, invasion, stemness and glycolysis through Wnt/β-catenin pathway

Influence of SLC40A1 on Cytokine Interactions and Immune Infiltration in Glioblastoma

Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells

Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway

Silencing of Survivin Using YM155 Inhibits Invasion and Suppresses Proliferation in Glioma Cells

Silibinin Inhibits Β-Catenin/zeb1 Signaling and Suppresses Bladder Cancer Metastasis Via Dual-Blocking Epithelial–mesenchymal Transition and Stemness

Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification

Simvastatin Inhibits Tumor Growth and Migration by Mediating Caspase-1-Dependent Pyroptosis in Glioblastoma Multiforme

BNIP3 Contributes to Silibinin-Induced DNA Double Strand Breaks in Glioma Cells Via Inhibition of Mtor.

Silibinin Induces G1 Arrest, Apoptosis and JNK/SAPK Upregulation in SW1990 Human Pancreatic Cancer Cells.

Silibinin induces apoptosis by caspase activation , down-regulating Bcl-2 and activating YAP / p 53 in renal cell carcinoma

Columbianadin suppresses glioblastoma progression by inhibiting the PI3K-Akt signaling pathway

Galangin (GLN) Suppresses Proliferation, Migration, and Invasion of Human Glioblastoma Cells by Targeting Skp2-Induced Epithelial–Mesenchymal Transition (EMT)

Effect of silibinin on proliferation of human bladder cancer cell 5637 in vitro and related mechanism